6-K
Foreign Interim / Material
MEIHUA INTERNATIONAL MEDICAL TECHNOLOGIES cO., LTD. MHUAF
0001213900-25-089047
- Filed
- Sep 18, 2025 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Diluted | Q2 2025 · Jun 30, 2025 | 31.9M sh |
| Shares Diluted | Q2 2025 · Jun 30, 2024 | 30.72M sh |
| Capex | Q2 2025 · Jun 30, 2025 | $10.24K |
| Capex | Q2 2025 · Jun 30, 2024 | $10.42K |
| Operating Cash Flow | Q2 2025 · Jun 30, 2025 | −$9.9M |
| Operating Cash Flow | Q2 2025 · Jun 30, 2024 | $1.02M |
| Short Term Debt | Q2 2025 · Jun 30, 2025 | ¥82M |
| Short Term Debt | Q2 2025 · Jun 30, 2025 | $11.45M |
| Short Term Debt | Q2 2025 · Dec 31, 2024 | ¥58M |
| Short Term Debt | Q2 2025 · Dec 31, 2024 | $7.95M |
| Stockholders Equity | Q2 2025 · Jun 30, 2025 | $164.95M |
| Stockholders Equity | Q2 2025 · Dec 31, 2024 | $158.98M |
| Current Liabilities | Q2 2025 · Jun 30, 2025 | $25.64M |
| Current Liabilities | Q2 2025 · Dec 31, 2024 | $27.26M |
| Total Liabilities | Q2 2025 · Jun 30, 2025 | $25.64M |
| Total Liabilities | Q2 2025 · Dec 31, 2024 | $27.26M |
| Current Assets | Q2 2025 · Jun 30, 2025 | $146.34M |
| Current Assets | Q2 2025 · Dec 31, 2024 | $143.44M |
| Total Assets | Q2 2025 · Jun 30, 2025 | $190.58M |
| Total Assets | Q2 2025 · Dec 31, 2024 | $186.24M |
| Eps Diluted | Q2 2025 · Jun 30, 2025 | $0.10 |
| Eps Diluted | Q2 2025 · Jun 30, 2024 | $0.17 |
| Eps Basic | Q2 2025 · Jun 30, 2025 | $0.10 |
| Eps Basic | Q2 2025 · Jun 30, 2024 | $0.19 |
| Sga Expense | Q2 2025 · Jun 30, 2025 | $2.71M |
| Sga Expense | Q2 2025 · Jun 30, 2024 | $3.5M |
| Rd Expense | Q2 2025 · Jun 30, 2025 | $1.33M |
| Rd Expense | Q2 2025 · Jun 30, 2024 | $1.46M |
| Net Income | Q2 2025 · Jun 30, 2025 | $3.15M |
| Net Income | Q2 2025 · Jun 30, 2024 | $4.72M |
| Operating Income | Q2 2025 · Jun 30, 2025 | $3.24M |
| Operating Income | Q2 2025 · Jun 30, 2024 | $5.89M |
| Gross Profit | Q2 2025 · Jun 30, 2025 | $12.61M |
| Gross Profit | Q2 2025 · Jun 30, 2024 | $15.19M |
| Cost Of Revenue | Q2 2025 · Jun 30, 2025 | $25.37M |
| Cost Of Revenue | Q2 2025 · Jun 30, 2024 | $30.16M |
| Revenue | Q2 2025 · Jun 30, 2025 | $37.98M |
| Revenue | Q2 2025 · Jun 30, 2024 | $45.34M |